作者
Max Wilkat, Hanna Bast, Robert Drees, Johannes Dünser, Amelie Mahr, Ninel Azoitei, Ralf Marienfeld, Felicia Frank, Magnus Brhel, Alexey Ushmorov, Jens Greve, Eva Goldberg‐Bockhorn, Marie‐Nicole Theodoraki, Johannes Doescher, Simon Laban, Patrick J Schuler, Thomas K Hoffmann, Cornelia Brunner
发表日期
2020/7/1
期刊
International journal of cancer
卷号
147
期号
1
页码范围
202-217
出版商
John Wiley & Sons, Inc.
简介
Adenosine is a signaling molecule that exerts dual effects on tumor growth: while it inhibits immune cell function and thereby prevents surveillance by the immune system, it influences tumorigenesis directly via activation of adenosine receptors on tumor cells at the same time. However, the adenosine‐mediated mechanisms affecting oncogenic processes particularly in head and neck squamous cell carcinomas (HNSCC) are not fully understood. Here, we investigated the role of adenosine receptor activity on HNSCC‐derived cell lines. Targeting the adenosine receptor A2B (ADORA2B) on these cells with the inverse agonist/antagonist PSB‐603 leads to inhibition of cell proliferation, transmigration as well as VEGFA secretion in vitro. At the molecular level, these effects were associated with cell cycle arrest as well as the induction of the apoptotic pathway. In addition, shRNA‐mediated downmodulation of ADORA2B …
引用总数
20202021202220232024238104